ARMISTICE CAPITAL, LLC purchased 1.1% of their position (510K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $344.1K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 3/7/2022ACC: 0000899243-22-009744
Director10% Owner
Since Jun 2018
+510K
Net shares
Net buyer
$344.1K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
510K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+50K
Price / share
$0.71
Trade value
$35.70K
% of position
0.1%
3/3/2022
46.84M→46.89M
Common Stock
Indirect
Shares
+135K
Price / share
$0.70
Trade value
$95.11K
% of position
0.3%
3/4/2022
46.89M→47.02M
Common Stock
Indirect
Shares
+325K
Price / share
$0.66
Trade value
$213.33K
% of position
0.7%
3/7/2022
47.02M→47.35M
Total
Net shares
+510K
Net value
$344.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/3/2022 | P · Purchase | +50K | $0.71 | $35.70K | 0.1% | 46.84M | 46.89M |
| Common Stock Indirect | 3/4/2022 | P · Purchase | +135K | $0.70 | $95.11K | 0.3% | 46.89M | 47.02M |
| Common Stock Indirect | 3/7/2022 | P · Purchase | +325K | $0.66 | $213.33K | 0.7% | 47.02M | 47.35M |
| Total | +510K | $344.13K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned412.44K
Total
412.44K direct412.44K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 412.44K | Direct |
| Total | 412.44K | 412.44K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported